Cyclo Therapeutics (CYTH)
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerati...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.7206
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- Unusual Whales · Feb 17 at 01:36 PM
Cyrano Therapeutics reports successful Phase 2 trial of CYR-064 for smell loss, advancing to Phase 3 in 2H 20206.
- GlobeNewswire · Oct 29, 2025 at 09:07 PM
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results
- Unusual Whales · Jun 11, 2025 at 11:22 AM
Rafael Holdings reports Q3 financials; Cyclo Therapeutics' Phase 3 trial for Niemann-Pick Disease fully enrolled, results due this month.
